Terms: = Liver cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1
101 results:
1. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
2. UBE2S promotes malignant properties via vhl/HIF-1α and vhl/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
Wu J; Xu X; Wu S; Shi W; Zhang G; Cao Y; Wang Z; Wu J; Jiang C
Cancer Med; 2023 Sep; 12(17):18078-18097. PubMed ID: 37563971
[TBL] [Abstract] [Full Text] [Related]
3. Prolonged hypoxia alleviates prolyl hydroxylation-mediated suppression of RIPK1 to promote necroptosis and inflammation.
Zhang T; Xu D; Liu J; Wang M; Duan LJ; Liu M; Meng H; Zhuang Y; Wang H; Wang Y; Lv M; Zhang Z; Hu J; Shi L; Guo R; Xie X; Liu H; Erickson E; Wang Y; Yu W; Dang F; Guan D; Jiang C; Dai X; Inuzuka H; Yan P; Wang J; Babuta M; Lian G; Tu Z; Miao J; Szabo G; Fong GH; Karnoub AE; Lee YR; Pan L; Kaelin WG; Yuan J; Wei W
Nat Cell Biol; 2023 Jul; 25(7):950-962. PubMed ID: 37400498
[TBL] [Abstract] [Full Text] [Related]
4. Potential role of circulating miR-21 in the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.
da Silva Freire AK; Furtado de Mendonça Belmont T; Pinto Santiago EJ; Cristina Cordeiro Farias I; Palmeira do Ó K; Soares da Silva A; Richardson Silva Vasconcelos L
Expert Rev Mol Diagn; 2022 Nov; 22(11):1037-1052. PubMed ID: 36348568
[TBL] [Abstract] [Full Text] [Related]
5. Targeting BCL-XL in fibrolamellar hepatocellular carcinoma.
Shebl B; Ng D; Lalazar G; Rosemore C; Finkelstein TM; Migler RD; Zheng G; Zhang P; Jiang CS; Qureshi A; Vaughan R; Yarchoan M; de Jong YP; Rice CM; Coffino P; Ortiz MV; Zhou D; Simon SM
JCI Insight; 2022 Sep; 7(17):. PubMed ID: 36073545
[TBL] [Abstract] [Full Text] [Related]
6. Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma.
Wang Y; Zheng XD; Zhu GQ; Li N; Zhou CW; Yang C; Zeng MS
Front Immunol; 2022; 13():861328. PubMed ID: 35479084
[TBL] [Abstract] [Full Text] [Related]
7. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract] [Full Text] [Related]
8. Histone chaperone FACT complex coordinates with HIF to mediate an expeditious transcription program to adapt to poorly oxygenated cancers.
Shen J; Yang C; Zhang MS; Chin DW; Chan FF; Law CT; Wang G; Cheng CL; Chen M; Wan RT; Wu M; Kuang Z; Sharma R; Lee TKW; Ng IO; Wong CC; Wong CM
Cell Rep; 2022 Feb; 38(5):110304. PubMed ID: 35108543
[TBL] [Abstract] [Full Text] [Related]
9. Bilateral Breast Radiation Associated Angiosarcoma After Radiotherapy for Bilateral Invasive Ductal Adenocarcinoma.
Vin Chang G; Xie C; Shahid M; Draine J; Alpers J; Reindl B; McHale M
S D Med; 2021 Jun; 74(6):260-263. PubMed ID: 34449165
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological features of sclerosing angiomatoid nodular transformation of the spleen.
Wang H; Hu B; Chen W; Ren J; Liu P; Shi H
Pathol Res Pract; 2021 Aug; 224():153490. PubMed ID: 34098199
[TBL] [Abstract] [Full Text] [Related]
11. Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome.
Penitenti F; Landoni L; Scardoni M; Piredda ML; Cingarlini S; Scarpa A; D'Onofrio M; Girelli D; Davi MV
Endocrine; 2021 Oct; 74(1):180-187. PubMed ID: 34036514
[TBL] [Abstract] [Full Text] [Related]
12. vhl-Related Neuroendocrine Neoplasms And Beyond: An Israeli Specialized Center Real-Life Report.
Szalat A; Oleinikov K; Nahmias A; Meiner V; Ben-Haim S; Atlan K; Lev-Cohain N; Appelbaum L; Gomori M; Mazeh H; Khalaileh A; Pe'er J; Lossos A; Shoshan Y; Grozinsky-Glasberg S; Gross DJ
Endocr Pract; 2020 Oct; 26(10):1131-1142. PubMed ID: 33471715
[TBL] [Abstract] [Full Text] [Related]
13. MiR-887 Promotes the Progression of Hepatocellular Carcinoma via Targeting vhl.
Zou W; Cheng J
Technol Cancer Res Treat; 2020; 19():1533033820940425. PubMed ID: 32912113
[TBL] [Abstract] [Full Text] [Related]
14. Dishevelled Associated Activator Of Morphogenesis (DAAM) Facilitates Invasion of Hepatocellular Carcinoma by Upregulating Hypoxia-Inducible Factor 1α (HIF-1α) Expression.
Fang X; Zhang D; Zhao W; Gao L; Wang L
Med Sci Monit; 2020 Aug; 26():e924670. PubMed ID: 32772041
[TBL] [Abstract] [Full Text] [Related]
15. DT2216-a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas.
He Y; Koch R; Budamagunta V; Zhang P; Zhang X; Khan S; Thummuri D; Ortiz YT; Zhang X; Lv D; Wiegand JS; Li W; Palmer AC; Zheng G; Weinstock DM; Zhou D
J Hematol Oncol; 2020 Jul; 13(1):95. PubMed ID: 32677976
[TBL] [Abstract] [Full Text] [Related]
16. Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines.
Sixto-López Y; Gómez-Vidal JA; de Pedro N; Bello M; Rosales-Hernández MC; Correa-Basurto J
Sci Rep; 2020 Jun; 10(1):10462. PubMed ID: 32591593
[TBL] [Abstract] [Full Text] [Related]
17. Ubiquitination of PPAR-gamma by pvhl inhibits ACLY expression and lipid metabolism, is implicated in tumor progression.
Noh KH; Kang HM; Yoo W; Min Y; Kim D; Kim M; Wang S; Lim JH; Jung CR
Metabolism; 2020 Sep; 110():154302. PubMed ID: 32589900
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies.
Sasijareonrat N; Jahn N; Ungprasert P; Owattanapanich W
Technol Cancer Res Treat; 2020; 19():1533033820937008. PubMed ID: 32583728
[TBL] [Abstract] [Full Text] [Related]
19. Third-line sunitinib treatment in a
Li X; Gao L; Zhang L; Sun H; Gou H
Cancer Biol Ther; 2020 Sep; 21(9):785-789. PubMed ID: 32552305
[TBL] [Abstract] [Full Text] [Related]
20. Correlation Between von Hippel-Lindau Gene Expression and Tumor SUVmax and Survival Prognosis in Hepatocellular Carcinoma.
Li G; Shen Y; Wang F; Hong S; Cai M
Med Sci Monit; 2020 Feb; 26():e920473. PubMed ID: 32075951
[TBL] [Abstract] [Full Text] [Related]
[Next]
